BI-6C9 is a highly specific BH3 interacting domain (Bid) inhibitor that prevented mitochondrial outer membrane potential (MOMP) and mitochondrial fission. Protects cells from mitochondrial apoptosis inducing factor (AIF) release and Caspase-independent cell death.

 

Brand: BCM

 

Target: Others; Mitochondrial Metabolism; Apoptosis

 

Signaling Pathways: Apoptosis; Metabolism; Others

 

pKa: 11.58±0.50(Predicted)

 

Solubility: Soluble in DMSO; soluble in Ethanol. Insoluble in Water.

 

GHS: GHS07

 

Isomeric SMILES: COC1=CC=C(C=C1)S(=O)(=O)NCCCC(=O)NC2=CC=C(C=C2)SC3=CC=C(C=C3)N  

 

InChIKey: LCFUJBSKPDPGKO-UHFFFAOYSA-N  

 

InChI: InChI=1S/C23H25N3O4S2/c1-30-19-8-14-22(15-9-19)32(28,29)25-16-2-3-23(27)26-18-6-12-21(13-7-18)31-20-10-4-17(24)5-11-20/h4-15,25H,2-3,16,24H2,1H3,(H,26,27)

 

Attribute
[Chem Name]	N-[4-(4-aminophenyl)sulfanylphenyl]-4-[(4-methoxyphenyl)sulfonylamino]butanamide
[Synonym]	BI-6C9; BI6C9
[CAS No.]	791835-21-7
[MDL No.]	MFCD07784498
[Formula]	C23H25N3O4S2
[Molecular]	471.59
[Form]	Off-white solid
[Storage]	Keep in dark place. Inert atmosphere. Room temperature

Goods Tag